Citywire printed articles sponsored by:
View the article online at http://citywire.co.uk/wealth-manager/article/a646759
Equity income: home is where the heart is?
Markets
by Dylan Lobo on Dec 27, 2012 at 07:00
‘In this way, many UK equity income funds benefit from global developments rather than UK-specific factors. For example, pharmaceutical companies – a favourite for many UK equity income funds – are benefiting from growing demand for their products and services in the emerging markets.’
It is statistics and anecdotal evidence like this that makes it difficult to abandon a market that has been so rewarding over the years.
All in the mind
Ultimately, however, it could be simple human nature that ensures UK funds remain prominent features on investors’ buy lists.
Seager-Scott says: ‘I think the reason they [UK equity income funds] have remained – and will continue to remain – popular is that for most developed economies, the majority of investors are likely to exhibit a natural home bias when it comes to equities. I think part of this is for pure investment reasons, and some of it is psychology.
‘From an investment point of view, investing overseas introduces an additional risk factor in the form of currency to a portfolio. It also keeps the manager’s investment universe limited to a relatively manageable size – after all, it is easier to have a reasonable working knowledge of most of the income-yielding companies in the UK than in the whole world.
‘There may also be a psychological element, where investors naturally feel more comfortable investing in a fund where they are familiar with a number of the stocks, being UK companies, than those that are overseas.’
- Previous page
- 1
- 2
- 3
- 4
- 5
News sponsored by:
Today's top headlines
More about this:
Look up the funds
Archive
Aberdeen Live supplement: Fundamentals point to ongoing flows and solid returns from EMD
After a record year for inflows and market-leading performance in 2012, emerging market debt has taken a large step towards the mainstream. Our recent debate covers the outlook for the asset class this year and where opportunities can be found.
On the road
Click here to find out more from the Audience Development team.
Read more...
Saturday Papers: News Corp poison pill shields Murdoch
by Himanshu Singh on May 25, 2013 at 00:01














leave a comment
Please sign in here or register here to comment. It is free to register and only takes a minute or two.